Skip to main content

Spasticity News

Blood Test Might Someday Diagnose Early MS

FRIDAY, April 19, 2024 – An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says. In one in 10 cases of...

High-Efficacy Therapy Cuts Disability Progression in Pediatric MS

FRIDAY, April 12, 2024 – Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study...

Christina Applegate Opens Up About the Agony of Fighting MS

TUESDAY, March 12, 2024 – Actress Christina Applegate, who has been battling multiple sclerosis (MS) since 2021, shared her struggles with the debilitating disease on Monday. “I live kind of in h...

Five Health Conditions Linked to Subsequent Diagnosis of MS

TUESDAY, Dec. 5, 2023 – Five health conditions are associated with subsequent diagnosis of multiple sclerosis, but they overlap with two other autoimmune diseases, according to a study published...

Higher Neurofilament Light Chain Levels Seen Before MS Disability Worsening

THURSDAY, Nov. 16, 2023 – Pronounced neuroaxonal damage precedes disability worsening events with or without preceding clinical relapses in people with multiple sclerosis (MS), according to a study...

Blood Test Might Predict Worsening of MS

KEY TAKEAWAYS: The progression of multiple sclerosis is particularly difficult to predict, varying widely between patients A new blood test uses a biomarker of nerve cell damage to accurately...

Relaxing Immersive Virtual Reality Interventions Acceptable, Feasible

TUESDAY, Oct. 17, 2023 – Relaxing immersive virtual reality (VR) interventions are acceptable and feasible and can offer benefits to patients with cancer, according to a review published online Oct....

MS-Specific Internet-Based Therapy Program Can Cut Depressive Symptoms

TUESDAY, Oct. 17, 2023 – A multiple sclerosis (MS)-specific internet-based cognitive behavioral therapy (iCBT) program can reduce depressive symptoms among patients with MS, according to a study...

Sociodemographic Factors Before MS Diagnosis Tied to Disease Severity

FRIDAY, Sept. 29, 2023 – Education, income, and marital status prior to multiple sclerosis (MS) onset are associated with future symptom and disability severity, according to a study published...

Emotional Issues Could Be Early Sign of MS

WEDNESDAY, Sept. 27, 2023 – A newer understanding of multiple sclerosis (MS) suggests that psychiatric conditions like anxiety and depression may emerge long before classic MS symptoms. “For a long t...

aHSCT Beneficial for Most Patients With Relapsing-Remitting MS

TUESDAY, Sept. 26, 2023 – Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most...

First Biosimilar, Tyruko, Approved to Treat Multiple Sclerosis

FRIDAY, Aug. 25, 2023 – The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of...

Patients Say Ketogenic Diet Aids Multiple Sclerosis Symptoms

MONDAY, Aug. 21, 2023 – Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition. Emma Wetmore,...

2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis

THURSDAY, July 27, 2023 – Oral disease-modifying therapies (DMTs) predominated new initiations for treatment of multiple sclerosis (MS) in 2020, according to a study published online July 10 in JAMA...

The Earlier MS Is Treated, the Better

WEDNESDAY, July 26, 2023 – Patients who get treatment for multiple sclerosis at the earliest signs of disease may have a lower risk of disability later, new research suggests. Among nearly 600...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Multiple Sclerosis

Related drug support groups

baclofen